RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Retained earnings

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.3B
P/E ratio
SummaryFinancials
Period EndRetained earnings (Million USD)YoY (%)
Dec 31, 2024-2,250+25.27%
Dec 31, 2023-1,796+25.62%
Dec 31, 2022-1,430+23.25%
Dec 31, 2021-1,160-7.16%
Dec 31, 2020-1,249+76.58%
Dec 31, 2019-708-26.85%
Dec 31, 2018-967-18.54%
Dec 31, 2017-1,187+0.51%
Dec 31, 2016-1,181+7.91%
Dec 31, 2015-1,095+8.77%
Dec 31, 2014-1,007+4.03%
Dec 31, 2013-968+6.69%
Dec 31, 2012-907+7.78%
Dec 31, 2011-841+11.21%
Dec 31, 2010-757

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)